Cue Biopharma, Inc. - COM (CUE)

Historical Portfolio Holders from Q1 2018 to Q2 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q2	6.12 K	$7.59 K	-$76 K			$1.24	2
2024 Q1	16.4 M	$31 M	+$2.72 M	73.9 K	24.4 K	$1.89	70
2023 Q4	14.9 M	$39.3 M	+$2.52 M	71.5 K	287 K	$2.64	78
2023 Q3	14 M	$32.1 M	-$624 K	71.3 K	59.1 K	$2.30	73
2023 Q2	13.8 M	$50.5 M	+$6.72 M	23.7 K	48.9 K	$3.65	77
2023 Q1	12.1 M	$43 M	-$2.54 M	8.93 K	103 K	$3.57	61
2022 Q4	12.8 M	$36.4 M	+$108 K	6.84 K	101 K	$2.85	60
2022 Q3	12.8 M	$28.6 M	-$2.59 M	0	70 K	$2.23	59
2022 Q2	13.6 M	$33.9 M	-$11.5 M	38 K	97 K	$2.49	65
2022 Q1	17.8 M	$86.7 M	+$4.42 M	444 K	866 K	$4.88	92
2021 Q4	16.5 M	$187 M	-$11.1 M	703 K	1.47 M	$11.31	86
2021 Q3	16.8 M	$244 M	-$24.9 M	662 K	1.53 M	$14.57	84
2021 Q2	18.2 M	$211 M	-$4.07 M	1.6 M	631 K	$11.65	87
2021 Q1	18.8 M	$229 M	-$6.38 M	3 M	707 K	$12.20	85
2020 Q4	19.3 M	$241 M	-$3.05 M	2.72 M	357 K	$12.51	92
2020 Q3	19.5 M	$294 M	+$50 M	453 K	635 K	$15.05	87
2020 Q2	16 M	$393 M	+$85.1 M	1.53 M	1.15 M	$24.51	98
2020 Q1	13 M	$184 M	+$36.6 M	329 K		$14.19	70
2019 Q4	10.5 M	$166 M	+$63.1 M			$15.88	59
2019 Q3	6.07 M	$51.2 M	+$13.3 M			$8.43	42
2019 Q2	4.48 M	$40.2 M	+$9.96 M			$8.99	34
2019 Q1	3.44 M	$26.6 M	+$1.87 M			$7.73	35
2018 Q4	3.21 M	$15.1 M	-$2.09 M			$4.70	32
2018 Q3	3.58 M	$32.4 M	+$3.24 M			$9.05	35
2018 Q2	3.14 M	$37.2 M	+$15.8 M			$11.86	33
2018 Q1	1.79 M	$25.1 M	+$25.1 M			$14.05	27